Research
Experimental compound burns fat without sacrificing muscle
The Brief
- UC Berkeley researchers identified an experimental compound that increases energy expenditure in mice.
- In mice, the compound boosted energy expenditure by up to 18%.
- The source reports improved blood sugar in the treated mice; the compound is not yet tested in humans per the excerpt provided.
Why it matters
The compound acts by increasing energy burn rather than suppressing appetite like GLP-1 drugs such as Ozempic and Wegovy, a mechanism that could matter for future obesity treatment research.
Who’s affected
- obesity and metabolism researchers
- clinicians and patients interested in weight-loss treatments
- #obesity
- #metabolism
- #weight loss
- #energy expenditure
- #mouse study
Researchers at UC Berkeley have identified a compound that could transform weight-loss treatment by helping the body burn more energy instead of suppressing appetite like Ozempic and Wegovy. In mice, the compound boosted energy expenditure by up to 18%, improved blood sugar…